2nd Lab Asset and Facility Management in Pharma Europe
March 19 - 21, 2024 - NLHanson Wade
info@hansonwade.com
Phone:+44 (0) 203 141 8730
The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of expediting operational excellence in laboratories across Europe. Join 80+ senior lab, R AND D operations, lab workplace strategy, lab equipment, and asset leaders from the likes of AstraZeneca, Novartis, and Abcam to: - Discuss asset optimisation and maintenance strategies to reduce equipment downtime - Expedite lab capabilities and overcome workspace constraints that will ensure a user-centric lab - Drive green practices – keeping sustainability at the forefront of decisions and exploring energy efficient strategies - Embrace the power of digitisation holistically within lab operations, and learn how to navigate your data lake by overcoming the challenge of various data outputs - Build long-lasting, dependable contract relationships to maximise value and improve equipment service capabilities - Explore strategies for incorporating and enhancing GxP to ensure an efficient R AND D scale up Time: 9:00 AM - 4:00 PM